Jeff Hall

While ChatGPT has the potential to help streamline responses to imaging-related questions from patients, the authors of a new study found that a third of ChatGPT responses to unprompted questions on medical imaging were not “fully relevant.”

In a newly published literature review, researchers examined the benefits of diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) for breast cancer characterization and monitoring of neoadjuvant chemotherapy, current drawbacks that thwart wider adoption, and emerging techniques that may enhance the modality’s effectiveness.

In a multicenter cohort of patients with interstitial lung disease (ILD), a deep learning classification tool demonstrated an 81 percent sensitivity rate and a 77 percent specificity rate for predicting usual interstitial pneumonia on computed tomography (CT) scans.

Artificial intelligence (AI) software assigned high malignancy risk scores to mammography exams completed up to two years prior to breast cancer diagnosis in over 38 percent of screen-detected cancer cases and over 39 percent of interval cancer cases, according to newly published research.

The Allia IGS Pulse reportedly has the first monopolar X-ray tube geared to interventional procedures.

Utilized in conjunction with screening digital mammography or digital breast tomosynthesis (DBT), the artificial intelligence (AI)-powered software cmAngio may help detect and localize breast arterial calcification (BAC), an incidental finding that has been linked to an elevated risk for heart disease and stroke.

Various organizations have applauded the decision by the CMS to remove National Coverage Determination (NCD) limitations to coverage for amyloid PET scans, including the limitation of Medicare or Medicaid coverage to one PET scan per a patient’s lifetime. It remains to be seen, however, how coverage decisions will be made by local Medicare Administrative Contractors (MACs).

Offering dedicated computed tomography (CT) assessment of the cardiovascular system, the SpotLight and SpotLight Duo systems reportedly provide high-resolution imaging for diagnosis and monitoring of cardiovascular diseases.

Combining phased and linear arrays on a single head, the Clarius PAL HD3 ultrasound device was unveiled at the recent American College of Emergency Physicians (ACEP) Scientific Assembly conference.

In a study of 355 multiparametric prostate MRI exams from a total of 71 scanners from 41 facilities in 18 countries, researchers found that only 23 scanners achieved a PI-QUAL score of 5 for optimal image quality.

In a study of over 25,000 Medicare beneficiaries with mild cognitive decline or dementia, researchers found that obtaining amyloid positron emission tomography (PET) scans resulted in no statistically significant differences upon subsequent hospitalization and emergency department visit rates at one year.

In a recently published literature review, researchers examined the potential impact of advanced sequences, scanners, patient preparation and AI on image quality for prostate MRI exams.

By leveraging subtle signals on routine X-rays to assess bone mineral density (BMD), the technology may facilitate earlier detection of osteoporosis and help prevent fragility fractures.

In reportedly the eighth FDA 510(k) clearance for Hyperfine’s Swoop portable brain MRI device, clinicians will now have access to enhanced denoising capabilities with diffusion-weighted imaging (DWI) sequences.

In a recent video interview, Ashesh Jani, M.D., discussed a subset analysis from the SPOTLIGHT trial that examined the utility of the PET PSMA agent flotufolastat F 18 (Posluma) for detecting prostate cancer recurrence in men with low PSA levels lower than 1 ng/mL.

Geared to clinicians who may lack ultrasound expertise, the artificial intelligence (AI)-powered Caption Guidance technology reportedly provides stepwise instruction for acquiring optimal cardiac ultrasound images.

In a study of over 500 people with carpal tunnel syndrome, researchers found that 57 percent returned to work three days after being treated with UltraGuideCTR, a modality which enables real-time ultrasound guidance for carpal tunnel release.

While the artificial intelligence (AI) triage system significantly reduced wait times for computed tomography pulmonary angiography (CTPA) results that were positive for pulmonary embolism (PE), researchers found no significant differences in the use of adjunctive AI with respect to accuracy rates and specificity rates.

In reportedly the first randomized study to compare hypofractionated radiation treatment versus conventional radiation treatment for women who had breast reconstruction procedures after mastectomy, researchers at the recent ASTRO conference noted similar rates of cancer recurrence, chest wall toxicity and patient well-being.

The Rology teleradiology platform may improve access to top tier-imaging interpretation for stand-alone imaging centers, rural facilities and low-income patients.

Integrating clinical data parameters along with chest X-ray findings, the multimodal artificial intelligence (AI) model outperformed the use of clinical parameters only and chest X-rays only for various conditions ranging from congestive heart failure and chronic kidney disease to hypertension and pneumonia.

Researchers found that the combination of a retrovesicourethral angle, functional urethral length, and bladder funnel on MRI exams in primiparous women had a 94.7 percent AUC for predicting postpartum stress urinary incontinence (SUI).

Leveraging artificial intelligence (AI) algorithms, the qXR-CTR reportedly provides automated cardiothoracic ratios (CTRs) through assessment of plain chest radiographs.

In a multicenter study examining four commercially available artificial intelligence (AI) software products for chest X-rays in over 2,000 patients, researchers found sensitivity rates ranging between 33 to 61 percent for vague airspace disease and 9 to 94 percent for small pneumothorax and pleural effusion.

Researchers noted a 20.1 percent incidence of bone-only metastasis in a cohort of men with castration-resistant prostate cancer, according to findings from research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

The MAGNETOM Viato.Mobile may facilitate improved access to MRI capabilities for patients with serious health conditions who lack geographic proximity to centers with advanced imaging.

For patients discharged from the hospital with confirmed COVID-19, median five-month follow-up MRI findings revealed a greater likelihood of regional brain volume reduction, parenchymal lung abnormalities and loss of corticomedullary differentiation in the kidney in comparison to people who have not had COVID-19.

Thirty-five percent of the interventional radiology malpractice cases involved vascular procedures and 26 percent of overall malpractice cases that went to trial resulted in plaintiff judgments with the average award being over $2 million.

The Exo Iris reportedly combines advanced silicon technology with imaging, workflow software and artificial intelligence (AI) to facilitate multidisciplinary use of point-of-care ultrasound.

The transitional pass-through payment reimbursement code for the FDA-approved PSMA PET agent for prostate cancer detection will be effective as of October 1, according to the Centers for Medicare and Medicare Services (CMS).